Publications in collaboration with researchers from Hospital Clinic Barcelona (49)

2024

  1. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting

    Diabetes care, Vol. 47, Núm. 2, pp. 216-224

  2. Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain

    Advances in Therapy

  3. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  4. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  5. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

  6. Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn's Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED)

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 906-923

  7. Response to Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224

    Diabetes care, Vol. 47, Núm. 5, pp. e46-e47

2023

  1. Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study

    Frontiers in Psychology, Vol. 14

  2. Physical activity patterns in type 1 diabetes in Spain: The SED1 study

    BMC Sports Science, Medicine and Rehabilitation, Vol. 15, Núm. 1

  3. RECALSEEN 2021. Resources and quality in the Endocrinology and Nutrition units of the National Health System of Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 7, pp. 459-467

  4. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly

    Frontiers in Endocrinology, Vol. 14

  5. Survey on Endocrinology and Nutrition undergraduate teaching in Spain-2021

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 36-49

2022

  1. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort

    European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801

  2. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO)

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 540-542

  3. How the COVID-19 pandemic has affected the training of Endocrinology and Nutrition Residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 219-226

2021

  1. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

    Journal of Clinical Investigation, Vol. 131, Núm. 20

  2. Cribado neonatal del hipotiroidismo congénito

    Revista espanola de salud publica, Vol. 95

  3. The SEEN comprehensive clinical survey of adult obesity: Executive summary

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 2, pp. 130-136

2020

  1. Fish oil enriched intravenous lipid emulsions reduce triglyceride levels in non-critically ill patients with TPN and type 2 diabetes. a post-hoc analysis of the INSUPAR study

    Nutrients, Vol. 12, Núm. 6

  2. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407